SCHEMBL25243476

SCHEMBL25243476

CCOC(=O)CC(N[S+]([O-])C(C)(C)C)c1cccc(N2C[C@@H](C)N[C@@H](C)C2)n1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GHSR Q92847 1/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ ACACB O00763 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MCHR1 Q99705 2/20 0.31
▸ CNR2 P34972 1/20 0.30
▸ HDAC1 Q13547 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SCARB1 Q8WTV0 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25235485 0.80 KCNB1 (0.34) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL25284925 0.79 HDAC1 (0.35) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL30457381 0.78 GHSR (0.34) GHSRACACBHDAC1
SCHEMBL25288325 0.78 GHSR (0.34) GHSRACACBHDAC1
SCHEMBL25288326 0.78 GHSR (0.34) GHSRACACBHDAC1
SCHEMBL25288327 0.78 GHSR (0.34) GHSRACACBHDAC1
SCHEMBL30671308 0.76 MAPT (0.38) LMNAMEN1ALDH1A1KMT2A
SCHEMBL31362647 0.74 SMN1; SMN2 (0.44) CYP1A2TSHRCYP2C19LMNAMEN1
SCHEMBL18640937 0.74 SMN1; SMN2 (0.44) CYP1A2TSHRCYP2C19LMNAMEN1
SCHEMBL20142638 0.71 ALDH1A1 (0.46) CYP1A2CYP2C9CYP2C19MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023110843-A1 HETEROBICYCLIC DERIVATIVES AS ITK INHIBITORS ALMIRALL, S.A. (ES) 2023-06-22 — — WO disclosed
Send feedback